We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Cardiology

Cardiac Alterations in Swimming-Induced Pulmonary Edema: Clinical Implications for Acute Evaluation

MedXY Editorial Team•Jul 13, 2026•Cardiology
cardiac functionDấu Hiệu Sinh Học TimechocardiographySwimming-Induced Pulmonary Edema

Highlight

  • Patients with SIPE exhibit transient mild systolic ventricular dysfunction detectable by transthoracic echocardiography (TTE) shortly after swimming.
  • Systolic pulmonary artery pressure is increased in a significant subset of SIPE patients compared with asymptomatic controls.
  • Cardiac biomarkers, such as high-sensitivity troponin I and NT-proBNP, are elevated in SIPE patients, suggesting myocardial stress or injury, but electrocardiogram (ECG) changes are not distinctive.
  • Clinical differentiation of SIPE from acute myocardial infarction requires careful assessment, as some patients may present with concurrent cardiac ischemia and elevated biomarkers.

Study Background

Swimming-induced pulmonary edema (SIPE) is an acute, potentially life-threatening condition characterized by fluid accumulation in the lungs during or after immersion in water, especially cold open-water swimming. Although SIPE is increasingly recognized in athletes and military personnel, its pathophysiology remains poorly defined. Cardiac involvement has been suggested in the literature, primarily from case reports, indicating transient cardiac dysfunction and biomarker elevation. Given the overlap of clinical features between SIPE and acute cardiac events, particularly myocardial infarction (MI), understanding the cardiac profile of SIPE patients is essential for appropriate diagnosis and management. This study addresses the unmet need for systematic characterization of cardiac findings in SIPE to guide acute assessment and avoid misdiagnosis.

Study Design and Methods

This prospective cohort study was conducted during Sweden’s largest open water swimming event, Vansbrosimningen, over the years 2022 to 2024. The study enrolled 45 patients who developed SIPE and 45 asymptomatic swimmers as matched controls. Inclusion criteria for SIPE cases involved acute onset of respiratory symptoms during or shortly after swimming, consistent with pulmonary edema. Controls had no respiratory or cardiac symptoms.

Participants underwent transthoracic echocardiography (TTE), standard 12-lead electrocardiogram (ECG), and measurement of cardiac biomarkers, including high-sensitivity cardiac troponin I and N-terminal pro-B-type natriuretic peptide (NT-proBNP), within 2 hours post-swim. Follow-up assessment with repeat investigations occurred up to 12 months to evaluate resolution of cardiac abnormalities.

Key Findings

The study revealed several important cardiac differences between SIPE patients and controls:

  • Systolic Ventricular Function: Mild impairment of systolic ventricular function, as assessed by TTE, was observed in 43% of SIPE patients compared to 10% of controls (p=0.003). This impairment was transient and improved on follow-up in almost all patients, indicating reversible cardiac stress rather than permanent damage.
  • Systolic Pulmonary Artery Pressure: Elevated systolic pulmonary artery pressure (>30% of patients) was unique to the SIPE group and absent in controls (p=0.005). This finding suggests elevated right heart afterload potentially linked to pulmonary vascular congestion.
  • Cardiac Biomarkers: High-sensitivity cardiac troponin I levels were increased in 67% of SIPE patients versus 40% of controls (median values 47 pg/ml vs. 14 pg/ml respectively, p<0.001). NT-proBNP was also significantly higher in SIPE patients (median 169 pg/ml) compared to controls (median 65 pg/ml, p<0.001). These elevations suggest myocardial strain rather than extensive necrosis in most cases.
  • Electrocardiogram Findings: No significant differences were found on post-swim ECG between SIPE patients and controls (p=0.746), indicating the absence of specific ischemic changes related to SIPE.
  • Concurrent Myocardial Infarction: Among the cohort, two SIPE patients were diagnosed with acute MI, presenting with severe chest pain and markedly elevated troponin levels. This underscores the need for clinical vigilance to distinguish SIPE from primary cardiac ischemia.

Expert Commentary

The findings advance our understanding of SIPE as a syndrome not only of pulmonary fluid accumulation but also of transient cardiac dysfunction. The reversible mild systolic impairment and elevated pulmonary artery pressures may reflect acute hemodynamic stress during immersion-related pulmonary edema formation. Biomarker elevations without corresponding ECG changes signify subclinical myocardial strain rather than frank infarction for most patients.

Clinicians should be aware that mild cardiac abnormalities on TTE and moderate elevation of troponin and NT-proBNP can be expected in SIPE and should not be overinterpreted as primary cardiac pathology unless accompanied by clinical or electrocardiographic evidence. These data provide a valuable benchmark for acute evaluation, ensuring appropriate triage and avoiding unnecessary invasive cardiac investigations. The coexistence of SIPE and MI, although uncommon, requires prompt recognition given differing management pathways.

Limitations include the single geographical setting and the relatively small sample size, which might limit generalizability. Further research could explore mechanistic pathways linking immersion-induced pulmonary edema to cardiac stress and potential preventive strategies.

Conclusion

This cohort study delineates the cardiac profile of patients with swimming-induced pulmonary edema, revealing transient mild systolic dysfunction, elevated pulmonary artery pressures, and increased cardiac biomarkers lacking distinctive ECG findings. These findings support a model of reversible cardiac strain as a component of SIPE pathology and provide a clinical reference framework for acute assessment. Distinguishing SIPE from acute myocardial infarction relies on integrated clinical, biomarker, imaging, and ECG data.

Funding and Clinical Trial Registration

The study was registered on clinicaltrials.gov (NCT05391737). Funding sources were not explicitly detailed in the abstract but should be consulted in the full publication for transparency.

References

1. Seiler C, et al. Cardiac findings in swimming-induced pulmonary edema – Implications for acute assessment. Chest. 2026 Jul 10. PMID: 42431395.
2. Moon RE et al. Swimming-induced pulmonary edema: pathophysiology and clinical management. Chest. 2017;152(5):934-943.
3. Shupak A. Immersion pulmonary edema: a syndrome in divers and swimmers. Med Sci Sports Exerc. 2016;48(11):2279-2285.
4. Anderson T, et al. Cardiac biomarkers in acute pulmonary edema: diagnostic and prognostic value. J Card Fail. 2020;26(5):374-378.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Cardiac Adaptations to Prolonged Spaceflight and Simulated Martian Gravity: Insights from a Longitudinal Observational StudyThis study explores cardiac structural and functional changes over prolonged spaceflight and simulated Martian gravity, revealing transient adaptations that stabilize without lasting detrimental effects, suggesting effective cardiovascularSep 17, 2026Aficamten’s Impact on Cardiac Function and Structure in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Insights from ACACIA-HCM TrialAficamten significantly improves diastolic function and cardiac structure in symptomatic nonobstructive hypertrophic cardiomyopathy, indicating benefits beyond outflow tract gradient reduction.Sep 3, 2026Advanced Right Ventricular Phenotyping Enhances Risk Stratification in Pulmonary Arterial Hypertension Follow-UpEchocardiography-derived right ventricular phenotypes improve prognostic accuracy beyond standard risk tools in pulmonary arterial hypertension patients at first follow-up, refining survival predictions and guiding management strategies.Aug 28, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing &amp; care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Pre-Transplant Left Atrial Volume Index as a Predictor of One-Year Morbidity after Kidney Transplantation: Insights and Implications
This study identifies pre-transplant left atrial volume index as a potential predictor for overall one-year morbidity following kidney transplantation, highlighting its clinical relevance beyond traditional cardiac risk markers.
Aug 12, 2026
Decoding the U-Shaped Relationship Between Left Ventricular Size and Mortality in Heart Failure PatientsA large Chinese cohort study reveals a U-shaped association between left ventricular end-diastolic diameter and mortality in heart failure, highlighting both small and large ventricular sizes as independent risk factors.Aug 7, 2026
Identifying Cardiovascular Subphenotypes in Sepsis: Toward Personalized Hemodynamic ManagementUnsupervised clustering of echocardiographic and hemodynamic data in sepsis reveals four distinct cardiovascular subphenotypes, each with unique mortality risks and responses to treatment, enabling personalized shock management strategies.Jul 7, 2026